Serina Therapeutics (SER) Capital Expenditures (2018 - 2025)
Serina Therapeutics (SER) posted Capital Expenditures of $13000.0 for Q3 2025, down 71.74% sequentially from $46000.0 in Q2 2025, and up 333.33% YoY from $3000.0 in Q3 2024.
Serina Therapeutics (SER) Capital Expenditures (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Capital Expenditures for 6 years, with the latest figure at $13000.0 in Q3 2025.
- Quarterly Capital Expenditures rose 333.33% year-over-year to $13000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $59000.0 (up 168.18% YoY) and the FY2025 annual result came in at $59000.0, up 168.18% from the prior year.
- Capital Expenditures declined to $13000.0 in Q3 2025 per SER's latest filing, from $46000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $119000.0 in Q3 2023 and troughed at $3000.0 in Q3 2024.
- A 3-year average of $38571.4 and a median of $14000.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures tumbled 97.48% in 2024, then soared 333.33% in 2025.
- Over 3 years, Capital Expenditures stood at $70000.0 in 2023, then sank by 92.86% to $5000.0 in 2024, then jumped by 160.0% to $13000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $13000.0, $46000.0, and $5000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 251.02 Mn |
| 10 | Serina Therapeutics | 44.65 Mn | 21.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |